Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Response to PEGINTERFERON and RIBAVIRIN Treatment in Patients With Chronic HCV Infection by Genetic Profile

NCT00272389 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00272389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00272389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Response to PEGINTERFERON and RIBAVIRIN Treatment in Patients With Chronic HCV Infection by Genetic Profile
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2006
Completion date
May 31, 2006
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus chronic infection